Expression of prohibitins on the surface of activated T cells

Biochemical and Biophysical Research Communications

Volumn 420, Issue 2, 2012, Pages 275-280

  Yurugi, Hajime ^a   Tanida, Shuhei ^a   Ishida, Akiko ^a   Akita, Kaoru ^a   Toda, Munetoyo ^a   Inoue, Mizue ^a   Nakada, Hiroshi ^a  

^a KYOTO SANGYO UNIVERSITY   (Japan)

Author keywords

Prohibitin; Signal transduction; T cell regulation

Indexed keywords

ANTIBODY; CD28 ANTIBODY; CD3 ANTIBODY; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROHIBITIN; PROHIBITIN 1; PROHIBITIN 2; PROTEIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELL SURFACE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES; CELL MEMBRANE; FEMALE; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; REPRESSOR PROTEINS; T-LYMPHOCYTES;

EID: 84859421874     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.149     Document Type: Article

References (24)

1. Mishra S., Murphy L.C., Murphy L.J. The prohibitins: emerging roles in diverse functions. J. Cell. Mol. Med. 2006, 10:353-363.
2. Mishra S., Ande S.R., Nyomba B.L.G. The role of prohibitin in cell signaling. FEBS J. 2010, 277:3937-3946.
3. Mishra S., Murphy L.C., Nyomba B., Murphy L.J. Prohibitin: a potential target for new therapeutics. Trends Mol. Med. 2005, 11:192-197.
4. Sanz M.A., Tsang W.Y., Willems E.M., Grivell L.A., Lemire B.D., van der Spek H., et al. The mitochondrial prohibitin complex is essential for embryonic viability and germline function in Caenorhabditis elegans. J. Biol. Chem. 2003, 278:32091.
5. Nijtmans L.G., de Jong L., Artal Sanz M., Coates P.J., Berden J.A., Back J.W., et al. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J. 2000, 19:2444-2451.
6. Chander H., Halpern M., Resnick-Silverman L., Manfredi J.J., Germain D. Skp2B attenuates p53 function by inhibiting prohibitin. EMBO Rep. 2010, 11:220-225.
7. Joshi B., Ko D., Ordonez-Ercan D., Chellappan S.P. A putative coiled-coil domain of prohibitin is sufficient to repress E2F1-mediated transcription and induce apoptosis. Biochem. Biophys. Res. Commun. 2003, 312:459-466.
8. Fusaro G., Dasgupta P., Rastogi S., Joshi B., Chellappan S. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 2003, 278:47853-47861.
9. Gamble S.C., Odontiadis M., Waxman J., Westbrook J.A., Dunn M.J., Wait R., et al. Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene 2004, 23:2996-3004.
10. Kim J.-W., Akiyama M., Park J.-H., Lin M.-L., Shimo A., Ueki T., et al. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer. Cancer Sci. 2009, 100:1468-1478.
11. Terashima M., Kim K.M., Adachi T., Nielsen P.J., Reth M., Köhler G., et al. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J. 1994, 13:3782-3792.
12. Rajalingam K., Wunder C., Brinkmann V., Churin Y., Hekman M., Sievers C., et al. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell Biol. 2005, 7:837-843.
13. Ross J.A., Nagy Z.S., Kirken R.A. The PHB1/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells. J. Biol. Chem. 2008, 283:4699-4713.
14. He B., Feng Q., Mukherjee A., Lonard D.M., DeMayo F.J., Katzenellenbogen B.S., et al. A repressive role for prohibitin in estrogen signaling. Mol. Endocrinol. 2008, 22:344-360.
15. S.-Eun Park, J. Xu, A. Frolova, L. Liao, B.W. O'Malley, B.S. Katzenellenbogen, Genetic deletion of the repressor of estrogen receptor activity (REA) enhances the response to estrogen in target tissues in vivo, Mol. Cell. Biol. 25 (2005) 1989-1999.
16. Sharma A., Qadri A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl. Acad. Sci. USA 2004, 101:17492-17497.
17. Kolonin M.G., Saha P.K., Chan L., Pasqualini R., Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 2004, 10:625-632.
18. Latchman Y., Wood C.R., Chernova T., Chaudhary D., Borde M., Chernova I., et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2001, 2:261-268.
19. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 270:985-988.
20. Nakaseko C., Miyatake S., Iida T., Hara S., Abe R., Ohno H., et al. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail. J. Exp. Med. 1999, 190:765-774.
21. Agata Y., Kawasaki A., Nishimura H., Ishida Y., Tsubata T., Yagita H., et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 1996, 8:765-772.
22. Ishida Y., Agata Y., Shibahara K., Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programed cell death. EMBO J. 1992, 11:3887-3895.
23. Leach D.R., Krummel M.F., Allison J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996, 271:1734-1736.
24. Kremer J.M., Westhovens R., Leon M., Di Giorgio E., Alten R., Steinfeld S., et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 2003, 349:1907-1915.